No abstract available
Keywords:
Hematological malignancies; IL-1R blockade; SARS-CoV-2.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antirheumatic Agents / pharmacology
-
Antirheumatic Agents / therapeutic use
-
COVID-19 / blood
-
COVID-19 Drug Treatment*
-
Female
-
Hematologic Neoplasms / blood
-
Hematologic Neoplasms / drug therapy*
-
Humans
-
Interleukin 1 Receptor Antagonist Protein / pharmacology
-
Interleukin 1 Receptor Antagonist Protein / therapeutic use*
-
Male
-
Middle Aged
-
Receptors, Interleukin-1 / antagonists & inhibitors*
-
SARS-CoV-2*
-
Severity of Illness Index*
-
Treatment Outcome
Substances
-
Antirheumatic Agents
-
Interleukin 1 Receptor Antagonist Protein
-
Receptors, Interleukin-1